Literature DB >> 29427210

A study of association of Oncotype DX recurrence score with DCE-MRI characteristics using multivariate machine learning models.

Ashirbani Saha1, Michael R Harowicz2, Weiyao Wang3, Maciej A Mazurowski2,4,5.   

Abstract

PURPOSE: To determine whether multivariate machine learning models of algorithmically assessed magnetic resonance imaging (MRI) features from breast cancer patients are associated with Oncotype DX (ODX) test recurrence scores.
METHODS: A set of 261 female patients with invasive breast cancer, pre-operative dynamic contrast enhanced magnetic resonance (DCE-MR) images and available ODX score at our institution was identified. A computer algorithm extracted a comprehensive set of 529 features from the DCE-MR images of these patients. The set of patients was divided into a training set and a test set. Using the training set we developed two machine learning-based models to discriminate (1) high ODX scores from intermediate and low ODX scores, and (2) high and intermediate ODX scores from low ODX scores. The performance of these models was evaluated on the independent test set.
RESULTS: High against low and intermediate ODX scores were predicted by the multivariate model with AUC 0.77 (95% CI 0.56-0.98, p < 0.003). Low against intermediate and high ODX score was predicted with AUC 0.51 (95% CI 0.41-0.61, p = 0.75).
CONCLUSION: A moderate association between imaging and ODX score was identified. The evaluated models currently do not warrant replacement of ODX with imaging alone.

Entities:  

Keywords:  Breast cancer MRI; Feature selection; Imaging features; Logistic regression; Oncotype DX; Radiomics

Mesh:

Year:  2018        PMID: 29427210      PMCID: PMC5920720          DOI: 10.1007/s00432-018-2595-7

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  30 in total

1.  Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.

Authors:  A S Coates; E P Winer; A Goldhirsch; R D Gelber; M Gnant; M Piccart-Gebhart; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2015-05-04       Impact factor: 32.976

2.  Interobserver variability in identification of breast tumors in MRI and its implications for prognostic biomarkers and radiogenomics.

Authors:  Ashirbani Saha; Lars J Grimm; Michael Harowicz; Sujata V Ghate; Connie Kim; Ruth Walsh; Maciej A Mazurowski
Journal:  Med Phys       Date:  2016-08       Impact factor: 4.071

3.  N4ITK: improved N3 bias correction.

Authors:  Nicholas J Tustison; Brian B Avants; Philip A Cook; Yuanjie Zheng; Alexander Egan; Paul A Yushkevich; James C Gee
Journal:  IEEE Trans Med Imaging       Date:  2010-04-08       Impact factor: 10.048

4.  A Validated Model for Identifying Patients Unlikely to Benefit From the 21-Gene Recurrence Score Assay.

Authors:  Michele M Gage; Martin Rosman; W Charles Mylander; Erica Giblin; Hyun-Seok Kim; Leslie Cope; Christopher Umbricht; Antonio C Wolff; Lorraine Tafra
Journal:  Clin Breast Cancer       Date:  2015-04-23       Impact factor: 3.225

5.  A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer.

Authors:  Ping Tang; Jianmin Wang; David G Hicks; Xi Wang; Linda Schiffhauer; Loralee McMahon; Qi Yang; Michelle Shayne; Alissa Huston; Kristin A Skinner; Jennifer Griggs; Gary Lyman
Journal:  Cancer Invest       Date:  2010-11       Impact factor: 2.176

6.  Radiogenomics: what it is and why it is important.

Authors:  Maciej A Mazurowski
Journal:  J Am Coll Radiol       Date:  2015-08       Impact factor: 5.532

7.  Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort.

Authors:  Ben S Wittner; Dennis C Sgroi; Paula D Ryan; Tako J Bruinsma; Annuska M Glas; Anitha Male; Sonika Dahiya; Karleen Habin; Rene Bernards; Daniel A Haber; Laura J Van't Veer; Sridhar Ramaswamy
Journal:  Clin Cancer Res       Date:  2008-05-15       Impact factor: 12.531

8.  Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer.

Authors:  Ming Fan; Hui Li; Shijian Wang; Bin Zheng; Juan Zhang; Lihua Li
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240

9.  Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis.

Authors:  Molly E Klein; David J Dabbs; Yongli Shuai; Adam M Brufsky; Rachel Jankowitz; Shannon L Puhalla; Rohit Bhargava
Journal:  Mod Pathol       Date:  2013-03-15       Impact factor: 7.842

10.  Radiomics: Images Are More than Pictures, They Are Data.

Authors:  Robert J Gillies; Paul E Kinahan; Hedvig Hricak
Journal:  Radiology       Date:  2015-11-18       Impact factor: 11.105

View more
  10 in total

1.  Contrast-Enhanced Mammography and Radiomics Analysis for Noninvasive Breast Cancer Characterization: Initial Results.

Authors:  Maria Adele Marino; Katja Pinker; Doris Leithner; Janice Sung; Daly Avendano; Elizabeth A Morris; Maxine Jochelson
Journal:  Mol Imaging Biol       Date:  2020-06       Impact factor: 3.488

Review 2.  Machine learning in breast MRI.

Authors:  Beatriu Reig; Laura Heacock; Krzysztof J Geras; Linda Moy
Journal:  J Magn Reson Imaging       Date:  2019-07-05       Impact factor: 4.813

3.  Deep Learning-Based Pathology Image Analysis Enhances Magee Feature Correlation With Oncotype DX Breast Recurrence Score.

Authors:  Hongxiao Li; Jigang Wang; Zaibo Li; Melad Dababneh; Fusheng Wang; Peng Zhao; Geoffrey H Smith; George Teodoro; Meijie Li; Jun Kong; Xiaoxian Li
Journal:  Front Med (Lausanne)       Date:  2022-06-14

4.  The volumetric-tumour histogram-based analysis of intravoxel incoherent motion and non-Gaussian diffusion MRI: association with prognostic factors in HER2-positive breast cancer.

Authors:  Chao You; Jianwei Li; Wenxiang Zhi; Yanqiong Chen; Wentao Yang; Yajia Gu; Weijun Peng
Journal:  J Transl Med       Date:  2019-07-02       Impact factor: 5.531

5.  Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.

Authors:  Doris Leithner; Blanca Bernard-Davila; Danny F Martinez; Joao V Horvat; Maxine S Jochelson; Maria Adele Marino; Daly Avendano; R Elena Ochoa-Albiztegui; Elizabeth J Sutton; Elizabeth A Morris; Sunitha B Thakur; Katja Pinker
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

Review 6.  A Systematic Review of Artificial Intelligence Techniques in Cancer Prediction and Diagnosis.

Authors:  Yogesh Kumar; Surbhi Gupta; Ruchi Singla; Yu-Chen Hu
Journal:  Arch Comput Methods Eng       Date:  2021-09-27       Impact factor: 8.171

7.  Is radiomic MRI a feasible alternative to OncotypeDX® recurrence score testing? A systematic review and meta-analysis.

Authors:  M G Davey; M S Davey; É J Ryan; M R Boland; P F McAnena; A J Lowery; M J Kerin
Journal:  BJS Open       Date:  2021-09-06

8.  Radiogenomics of magnetic resonance imaging and a new multi-gene classifier for predicting recurrence prognosis in estrogen receptor-positive breast cancer: A preliminary study.

Authors:  Yukiko Tokuda; Masahiro Yanagawa; Kaori Minamitani; Yasuto Naoi; Shinzaburo Noguchi; Noriyuki Tomiyama
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

9.  An investigation of machine learning methods in delta-radiomics feature analysis.

Authors:  Yushi Chang; Kyle Lafata; Wenzheng Sun; Chunhao Wang; Zheng Chang; John P Kirkpatrick; Fang-Fang Yin
Journal:  PLoS One       Date:  2019-12-13       Impact factor: 3.240

Review 10.  Lymph Node Imaging in Patients with Primary Breast Cancer: Concurrent Diagnostic Tools.

Authors:  Maria Adele Marino; Daly Avendano; Pedro Zapata; Christopher C Riedl; Katja Pinker
Journal:  Oncologist       Date:  2019-10-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.